These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 8390996)
1. Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression. Monia BP; Lesnik EA; Gonzalez C; Lima WF; McGee D; Guinosso CJ; Kawasaki AM; Cook PD; Freier SM J Biol Chem; 1993 Jul; 268(19):14514-22. PubMed ID: 8390996 [TBL] [Abstract][Full Text] [Related]
2. Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids. Lima WF; Crooke ST Biochemistry; 1997 Jan; 36(2):390-8. PubMed ID: 9003192 [TBL] [Abstract][Full Text] [Related]
3. Uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets. Kawasaki AM; Casper MD; Freier SM; Lesnik EA; Zounes MC; Cummins LL; Gonzalez C; Cook PD J Med Chem; 1993 Apr; 36(7):831-41. PubMed ID: 8464037 [TBL] [Abstract][Full Text] [Related]
4. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides. Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654 [TBL] [Abstract][Full Text] [Related]
5. Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras. Monia BP; Johnston JF; Sasmor H; Cummins LL J Biol Chem; 1996 Jun; 271(24):14533-40. PubMed ID: 8662854 [TBL] [Abstract][Full Text] [Related]
6. Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides. Moulds C; Lewis JG; Froehler BC; Grant D; Huang T; Milligan JF; Matteucci MD; Wagner RW Biochemistry; 1995 Apr; 34(15):5044-53. PubMed ID: 7536034 [TBL] [Abstract][Full Text] [Related]
7. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology. Gao WY; Han FS; Storm C; Egan W; Cheng YC Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582 [TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. Monia BP; Johnston JF; Ecker DJ; Zounes MA; Lima WF; Freier SM J Biol Chem; 1992 Oct; 267(28):19954-62. PubMed ID: 1400312 [TBL] [Abstract][Full Text] [Related]
17. 2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivo. Prakash TP; Johnston JF; Graham MJ; Condon TP; Manoharan M Nucleic Acids Res; 2004; 32(2):828-33. PubMed ID: 14762210 [TBL] [Abstract][Full Text] [Related]
18. Rational design of point mutation-selective antisense DNA targeted to codon 12 of Ha-ras mRNA in human cells. Duroux I; Godard G; Boidot-Forget M; Schwab G; Hélène C; Saison-Behmoaras T Nucleic Acids Res; 1995 Sep; 23(17):3411-8. PubMed ID: 7567450 [TBL] [Abstract][Full Text] [Related]
19. Control of complexity constraints on combinatorial screening for preferred oligonucleotide hybridization sites on structured RNA. Bruice TW; Lima WF Biochemistry; 1997 Apr; 36(16):5004-19. PubMed ID: 9125523 [TBL] [Abstract][Full Text] [Related]
20. Characterization of antisense oligonucleotides comprising 2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (FANA): specificity, potency, and duration of activity. Ferrari N; Bergeron D; Tedeschi AL; Mangos MM; Paquet L; Renzi PM; Damha MJ Ann N Y Acad Sci; 2006 Oct; 1082():91-102. PubMed ID: 17145930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]